Kimia T. Maleki

3.5k total citations
16 papers, 433 citations indexed

About

Kimia T. Maleki is a scholar working on Infectious Diseases, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kimia T. Maleki has authored 16 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 6 papers in Immunology and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kimia T. Maleki's work include Viral Infections and Vectors (7 papers), Viral Infections and Outbreaks Research (5 papers) and Immune Cell Function and Interaction (5 papers). Kimia T. Maleki is often cited by papers focused on Viral Infections and Vectors (7 papers), Viral Infections and Outbreaks Research (5 papers) and Immune Cell Function and Interaction (5 papers). Kimia T. Maleki collaborates with scholars based in Sweden, Germany and Iran. Kimia T. Maleki's co-authors include Niklas K. Björkström, Martin Cornillet, Jonas Klingström, Hans‐Gustaf Ljunggren, Ben Ingram, Yaser Ostovari, Afshin Honarbakhsh, Clas Ahlm, Marina García and Anna Smed‐Sörensen and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Kimia T. Maleki

15 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kimia T. Maleki Sweden 11 204 104 70 63 47 16 433
Heng Chin Low Malaysia 13 76 0.4× 40 0.4× 19 0.3× 35 0.6× 49 1.0× 31 398
Laura Wise Portugal 9 63 0.3× 9 0.1× 110 1.6× 19 0.3× 15 0.3× 18 311
Yu Kong China 12 169 0.8× 51 0.5× 234 3.3× 31 0.5× 170 3.6× 28 684
Luping Li China 7 93 0.5× 25 0.2× 76 1.1× 9 0.1× 23 0.5× 19 323
Antonio Furlan Italy 12 75 0.4× 126 1.2× 15 0.2× 6 0.1× 304 6.5× 26 752
Robert Douglas United States 7 44 0.2× 15 0.1× 36 0.5× 20 0.3× 122 2.6× 8 438
Rishika Banydeen Martinique 10 25 0.1× 11 0.1× 28 0.4× 17 0.3× 32 0.7× 39 306
Lois H. Dickerman United States 13 53 0.3× 13 0.1× 21 0.3× 22 0.3× 143 3.0× 21 466
Amy Woodward United States 8 21 0.1× 97 0.9× 8 0.1× 4 0.1× 54 1.1× 12 324
Michael A. Callahan United States 16 21 0.1× 15 0.1× 7 0.1× 17 0.3× 157 3.3× 28 769

Countries citing papers authored by Kimia T. Maleki

Since Specialization
Citations

This map shows the geographic impact of Kimia T. Maleki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimia T. Maleki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimia T. Maleki more than expected).

Fields of papers citing papers by Kimia T. Maleki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimia T. Maleki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimia T. Maleki. The network helps show where Kimia T. Maleki may publish in the future.

Co-authorship network of co-authors of Kimia T. Maleki

This figure shows the co-authorship network connecting the top 25 collaborators of Kimia T. Maleki. A scholar is included among the top collaborators of Kimia T. Maleki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimia T. Maleki. Kimia T. Maleki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Maleki, Kimia T., et al.. (2025). Computational study of levodopa adsorption on Al-doped BNNTs using DFT and QTAIM for medical application. Results in Chemistry. 18. 102775–102775.
2.
Maleki, Kimia T., et al.. (2025). IL-6 trans-signaling mediates cytokine secretion and barrier dysfunction in hantavirus-infected cells and correlates to severity in HFRS. PLoS Pathogens. 21(4). e1013042–e1013042. 1 indexed citations
3.
García, Marina, Wanda Christ, Ronaldo Lira‐Junior, et al.. (2024). Innate lymphoid cells are activated in HFRS, and their function can be modulated by hantavirus-induced type I interferons. PLoS Pathogens. 20(7). e1012390–e1012390. 2 indexed citations
5.
Jiang, Xiaojun, Annika Bergquist, Britt-Sabina Löscher, et al.. (2021). A heterozygous germline CD100 mutation in a family with primary sclerosing cholangitis. Science Translational Medicine. 13(582). 15 indexed citations
6.
Maleki, Kimia T., Johanna Tauriainen, Marina García, et al.. (2021). MAIT cell activation is associated with disease severity markers in acute hantavirus infection. Cell Reports Medicine. 2(3). 100220–100220. 14 indexed citations
7.
Lagerqvist, Nina, Kimia T. Maleki, Joakim Dillner, et al.. (2021). Evaluation of 11 SARS-CoV-2 antibody tests by using samples from patients with defined IgG antibody titers. Scientific Reports. 11(1). 7614–7614. 22 indexed citations
8.
Glans, Hedvig, Sara Gredmark‐Russ, Sara Falck‐Jones, et al.. (2021). Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses. BMC Infectious Diseases. 21(1). 494–494. 10 indexed citations
9.
Varnaitė, Renata, Marina García, Hedvig Glans, et al.. (2020). Expansion of SARS-CoV-2–Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients. The Journal of Immunology. 205(9). 2437–2446. 56 indexed citations
10.
García, Marina, Efthymia Kokkinou, Tiphaine Parrot, et al.. (2020). Innate lymphoid cell composition associates with COVID‐19 disease severity. Clinical & Translational Immunology. 9(12). e1224–e1224. 53 indexed citations
11.
Klingström, Jonas, Anna Smed‐Sörensen, Kimia T. Maleki, et al.. (2019). Innate and adaptive immune responses against human Puumala virus infection: immunopathogenesis and suggestions for novel treatment strategies for severe hantavirus‐associated syndromes. Journal of Internal Medicine. 285(5). 510–523. 39 indexed citations
12.
Gupta, Shawon, Kimia T. Maleki, Patricia González-Rodríguez, et al.. (2019). Hantavirus Inhibits TRAIL-Mediated Killing of Infected Cells by Downregulating Death Receptor 5. Cell Reports. 28(8). 2124–2139.e6. 24 indexed citations
13.
Maleki, Kimia T., Marina García, Ulf Hammar, et al.. (2019). Serum Markers Associated with Severity and Outcome of Hantavirus Pulmonary Syndrome. The Journal of Infectious Diseases. 219(11). 1832–1840. 26 indexed citations
14.
Ostovari, Yaser, et al.. (2019). GIS and multi-criteria decision-making analysis assessment of land suitability for rapeseed farming in calcareous soils of semi-arid regions. Ecological Indicators. 103. 479–487. 86 indexed citations
15.
Baharom, Faezzah, Gregory Rankin, Kimia T. Maleki, et al.. (2017). Human hantavirus infection elicits pronounced redistribution of mononuclear phagocytes in peripheral blood and airways. PLoS Pathogens. 13(6). e1006462–e1006462. 26 indexed citations
16.
Maleki, Kimia T., Martin Cornillet, & Niklas K. Björkström. (2015). Soluble SEMA4D/CD100: A novel immunoregulator in infectious and inflammatory diseases. Clinical Immunology. 163. 52–59. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026